Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Net (2013 - 2021)
Viridian Therapeutics, Inc.\DE (VRDN) reported Receivables - Net of $1 million for Q3 2021, compared with $57,000 a year earlier.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Net (2013 - 2021) Analysis & Trends
At the end of FY2019, Viridian Therapeutics, Inc.\DE posted Receivables - Net of $108,000, up 350.0% from FY2018.
- Receivables - Net has a five-year compound annual growth rate of -37.0% (FY2014 to FY2019).
- By year, Receivables - Net came in at $24,000 in FY2018 (-98.4%), $1.46 million in FY2017, $20,000 in FY2016 (-94.9%) and $394,000 in FY2015 (-63.8%).
- The Q3 2021 figure ranks as the highest quarterly Receivables - Net since Q3 2018.
- Year over year, Receivables - Net gained in 1 of the last four quarters, with growth averaging 49.7%.
- The high point for year-over-year Receivables - Net in five years was Q4 2019 (growth of 350.0%); the low point was Q1 2019 (a decline of 99.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | 2.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 1.00 Mn |
| Sep 30, 2020 | 57,000.00 |
| Jun 30, 2020 | 248,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 108,000.00 |
| Sep 30, 2019 | 979,000.00 |
| Jun 30, 2019 | 325,000.00 |
| Mar 31, 2019 | 6,000.00 |
| Dec 31, 2018 | 24,000.00 |
| Sep 30, 2018 | 1.38 Mn |
| Jun 30, 2018 | 1.20 Mn |
| Mar 31, 2018 | 4.81 Mn |
| Dec 31, 2017 | 1.46 Mn |
| Sep 30, 2017 | 635,000.00 |
| Jun 30, 2017 | 539,000.00 |
| Mar 31, 2017 | 277,000.00 |
| Dec 31, 2016 | 20,000.00 |
| Sep 30, 2016 | 733,000.00 |
| Jun 30, 2016 | 658,000.00 |
| Mar 31, 2016 | 490,000.00 |
API Access
Viridian Therapeutics, Inc.\DE Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();